ATAI
ATAI Life Sciences BV
NASDAQ: ATAI · HEALTHCARE · BIOTECHNOLOGY
$4.12
-4.85% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
369.70x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$1 – $7
Volume
6.2M
ATAI Life Sciences BV (ATAI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |